HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.

AbstractOBJECTIVE:
Our earlier studies have shown that MLT exerts the inhibitory effect on murine cancer via membrane and nuclear receptors. We have found that the antagonist of MT1 receptors does not diminish the antiproliferative effect of MLT on Colon 38 cells, and the contribution of MT2 receptors has been suggested to be responsible. Therefore, in the present study we have examined the influence of the 4-phenyl-2-propionamidotetralin (4P-PDOT), which is a selective antagonist of MT2 membrane receptor, and luzindole - an antagonist of both membrane receptors, on an oncostatic action of MLT.
MATERIALS AND METHODS:
The murine cancer cell line Colon 38 was used in the experiments. In 48 hrs cell culture the effects of MLT, 4P-PDOT and luzindole administered alone and MLT applied jointly with either 4P-PDOT or luzindole were examined. The growth of cancer cells was assessed using the modified colorimetric Mosmann method.
RESULTS:
Melatonin at both examined concentrations (10-7, 10-9 M) significantly decreased the viability of cancer cells. The selective antagonist of MT2 membrane receptor, namely 4P-PDOT and luzindole applied separately did not have an effect on the growth of Colon 38 cells. The addition of 4P-PDOT to MLT did not change the inhibitory effect of MLT, whereas luzindole given together with MLT diminished, but failed to block totally, the oncostatic properties of MLT.
CONCLUSIONS:
The obtained data and our previous studies conducted on Colon 38 cancer indicate that membrane melatonin receptors are not indispensable to the oncostatic action of melatonin and thus other pathways such as nuclear signaling and receptor-independent mechanism may be also involved.
AuthorsKatarzyna Winczyk, Julita Fuss-Chmielewska, Hanna Lawnicka, Marek Pawlikowski, Michal Karasek
JournalNeuro endocrinology letters (Neuro Endocrinol Lett) Vol. 30 Issue 5 Pg. 657-62 ( 2009) ISSN: 0172-780X [Print] Sweden
PMID20035258 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 4-phenyl-2-propionamidotetraline
  • Receptors, Melatonin
  • Tetrahydronaphthalenes
  • Tryptamines
  • luzindole
  • Melatonin
Topics
  • Animals
  • Cell Line, Tumor
  • Colonic Neoplasms (metabolism, pathology)
  • Humans
  • Melatonin (metabolism)
  • Mice
  • Receptors, Melatonin (antagonists & inhibitors, metabolism)
  • Tetrahydronaphthalenes (metabolism, pharmacology)
  • Tryptamines (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: